However, contrary to the negative prognostic significance of ESRP1, ESRP1 has been shown to inhibit the growth of prostate cancer xenografts using androgen receptor-negative prostate cancer cells in vivo [61]. The gene discussed is ESRP1; the disease is prostate cancer.